SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma
SKA1/2/3 may serve as promising biomarkers for the prognosis and diagnosis of ESCA, which holds promise as a novel therapeutic target for the disease.
Authors
- Lina Wang (ORCID: https://orcid.org/0000-0003-1457-0015)
- Liming Zhang (ORCID: https://orcid.org/0000-0002-1595-2296)
- Shaoqiang Wang (ORCID: https://orcid.org/0000-0001-8964-474X)
Institutions
- Weifang People's Hospital (CN)
- Affiliated Hospital of Jining Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1186/s12885-024-13257-8
- Citations
- 3
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- National Natural Science Foundation of China